King Simona 4
4 · Passage BIO, Inc. · Filed Aug 1, 2023
Insider Transaction Report
Form 4
King Simona
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-07-28+31,250→ 35,447 total - Sale
Common Stock
2023-07-28$0.88/sh−11,453$10,079→ 23,994 total - Exercise/Conversion
Restricted Stock Units
2023-07-28−31,250→ 0 total→ Common Stock (31,250 underlying)
Footnotes (3)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a "sell to cover" transaction.
- [F3]Represents accelerated vesting of RSUs previously granted pursuant to the 2020 Equity Incentive Plan pursuant to a separation agreement between the Reporting Person and the Issuer.